Reviews · Indian journals 2026

Medical Oncology: top review articles from Indian journals

The 27 narrative reviews from Indian journals in 2026 most worth a resident's time in Medical Oncology, ranked by how useful each is for exams and practice and by the standing of the journal. Each title opens the article on the journal's own website.

Reviews 27

  1. 1. The immunotherapy arsenal against upper gastrointestinal tumours: A comprehensive review of immune checkpoint inhibitors across neoadjuvant, adjuvant, and metastatic settings
    Ahmed Sohaib, Muhammad Abulfadl, Hany F Moawad et al. · South Asian Journal of Cancer, Sep 2026
    Read article
  2. 2. Beyond the Scalpel: Why FLOT Changed Gastric Cancer—Biological Rationale, Evidence, and Regional Relevance
    Ramanuj Mukherjee, Sayan Kundu, Sagar Sen et al. · Indian Journal of Medical and Paediatric Oncology, Aug 2026
    Read article
  3. 3. Advances and future perspectives in the treatment of small cell lung cancer: From chemotherapy and radiotherapy to the era of targeted therapy and immunotherapy
    Xiangwei Cheng, Weibin Lv, Linfeng Wu et al. · Journal of Cancer Research and Therapeutics, Aug 2026
    Read article
  4. 4. De-escalation and Selective Omission of Adjuvant Chemotherapy in Early Breast Cancer
    Krishnan Chandralekha, Amol Akhade, Bhawna Sirohi · Indian Journal of Medical and Paediatric Oncology, Apr 2026
    Read article
  5. 5. Impact of diabetes mellitus in cancer
    Hadrian Noel Alexander F., Sandeep Muzumder, Silpa Johnson et al. · The Indian Journal of Medical Research, Mar 2026
    Read article
  6. 6. Epidermal growth factor receptor as a target enzyme in cancer therapy: Structural and functional insights from crystallography
    Vidya Kishanrao Magar, Karna Khavane, Anita Wagh et al. · Indian Journal of Pharmacology, Jul 2026
    Read article
  7. 7. Tislelizumab—Current Status and Future Directions: A Review Article
    Praloy Basu · Indian Journal of Medical and Paediatric Oncology, Feb 2026
    Read article
  8. 8. Evolution and breakthroughs of RAS-targeted therapy: A narrative review
    Chinmoy K Bose · Cancer Research Statistics and Treatment, Jun 2026
    Read article
  9. 9. Anti-diabetic Drugs and Cancer: Integrated Mechanisms of Tumor Suppression and Clinical Translation
    Mahya Asadalizadeh, Mohammad Kazem Molavi Rahbar, Tabassom Mahmoudie et al. · Indian Journal of Clinical Biochemistry, Apr 2026
    Read article
  10. 10. Hazard ratios in clinical research: Interpretation, assumptions, and common pitfalls
    Vanidha Kandasamy · Perspectives in Clinical Research, Oct 2026
    Read article
  11. 11. Artificial Intelligence in Oncology Clinical Practice: From Initial Patient Assessment to Outcome Prediction
    Ganesh Divekar, Bharat Bhosale · Indian Journal of Medical and Paediatric Oncology, Jul 2026
    Read article
  12. 12. Lung Cancer in Non-Smokers: Molecular, Immunological and Potential Therapeutic Approaches
    Debanik Deb, Sumit Ghosh, Shauryabrota Dalui et al. · Indian Journal of Clinical Biochemistry, May 2026
    Read article
  13. 13. The advanced research of immunotherapy in Epidermal growth factor receptor mutation-positive non-small cell lung cancer
    Xinjia He, Tiantian Tian, Yanjing Ma et al. · Journal of Cancer Research and Therapeutics, May 2026
    Read article
  14. 14. Zolbetuximab: A Narrative Drug Review
    Alma Rose Devasia, Keechilat Pavithran · Indian Journal of Medical and Paediatric Oncology, Feb 2026
    Read article
  15. 15. Current status and future prospects of immunotherapy for pancreatic ductal adenocarcinoma
    Yun Lou, Huiling Zhou, Fangtao Liu et al. · Journal of Cancer Research and Therapeutics, May 2026
    Read article
  16. 16. Posttransplant Malignancy
    A. W. Adeyemo, Sourabh Sharma, O. O. Olatise et al. · Indian Journal of Transplantation, Apr 2026
    Read article
  17. 17. Diabetes Mellitus and Oncology: A Comprehensive Review
    Mayank Kapoor, Amisha Kapoor, Ravi Kant · Indian Journal of Medical and Paediatric Oncology, Apr 2026
    Read article
  18. 18. Telemedicine for Cancer Care in Resource-Constrained Settings: Benefits, Barriers, and Implementation Priorities
    Akhil Kapoor, Gaurav Redkar, Archi Rungta et al. · Indian Journal of Medical and Paediatric Oncology, Aug 2026
    Read article
  19. 19. Zongertinib and Sevabertinib for Her2-Mutant Non-Small Cell Lung Cancer
    Goutham Sunny, Praloy Basu, Rajan Yadav · Indian Journal of Medical and Paediatric Oncology, Feb 2026
    Read article
  20. 20. Neoadjuvant versus Adjuvant Immunotherapy in MSI-H/dMMR Early Colorectal Cancer: A Value-Conscious Re-examination of Dogma
    Barnini Ghosh, Amol Akhade · Indian Journal of Medical and Paediatric Oncology, Apr 2026
    Read article
  21. 21. Review-based investigation on cancer statistics 2022: India at a glance
    Sukhjot Kaur, Zohra Khatoon · Indian Journal of Cancer, Apr 2026
    Read article
  22. 22. Progress in metabolic reprogramming of gastric malignant tumors to remodel tumor immune microenvironments
    Na Wang, Kai Wang, Feixue Song · Journal of Cancer Research and Therapeutics, Mar 2026
    Read article
  23. 23. Zongertinib: A Novel Therapeutic Advance in HER2-Mutant Non-Small Cell Lung Cancer
    Pawan Agarwal, Rahul Gangoda, Manoj Sharma et al. · Indian Journal of Medical and Paediatric Oncology, Feb 2026
    Read article
  24. 24. Liquid Biopsy in Precision Oncology: Clinical Applications of Circulating Tumor DNA and Circulating Tumor Cells
    Prabhat Ganju · Indian Journal of Medical and Paediatric Oncology, Aug 2026
    Read article
  25. 25. The Current Landscape of Nanopaclitaxel Formulations and the Benefits of Polymeric Micellar Paclitaxel in Solid Tumors
    Vaibhav Choudhary, Nirmal Raut, Gajanan Panchal et al. · Indian Journal of Medical and Paediatric Oncology, Jan 2026
    Read article
  26. 26. Chimeric antigen receptor-based immunotherapies in cancer treatment: An Indian perspective
    Ajit Kulkarni, Akshita Kulkarni, Nilesh Kumar Sharma · Indian Journal of Physiology and Pharmacology, Jun 2026
    Read article
  27. 27. A Review of Bispecific T-cell Engagers (BiTEs): A Promising Strategy in the Evolving Landscape of Cancer Immunotherapy
    Chinmoy K. Bose · Indian Journal of Medical and Paediatric Oncology, Jun 2026
    Read article